Back to search

Article

Histone H3S28 Phosphorylation Promotes a Senescence-Associated Survival Program Following PARP Inhibition in Hormone Receptor-Positive Breast Cancer

2026-08-06

Abstract excerpt

<title>Abstract</title> <p> Background: PARP1 inhibitors (PARPi) are a key therapeutic strategy in BRCA1/2-mutated and increasingly in homologous recombination (HR)-positive breast cancers. However, resistance and relapse remain major challenges. While most studies focus on DNA repair restoration, chromatin-based mechanisms of PARPi response are less understood. PARP1 regulates DNA repair and chromatin organisat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9adbfaf-2469-5874-8936-58f73e6b7b6b
DOI
10.21203/rs.3.rs-10431382/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Histone H3S28 Phosphorylation Promotes a Senescence-Associated Survival Program Following PARP Inhibition in Hormone Receptor-Positive Breast CancerDOI 10.21203/rs.3.rs-10431382/v1
Select a neighboring publication to make it the new centre.